chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Fatigue, Headache
Clinical narrative: I've lost so much sleep,I can barely sleep; a lot of coughing every now and then; a lot of phlegm; soreness in my arm; chills; fever; tiredness; headaches daily; Muscle pain; Joint pain; nausea; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm) and CHILLS (chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure high. Concomitant products included INSULIN HUMAN (NOVOLIN R), INSULIN GLARGINE (LANTUS), ACETYLSALICYLIC ACID (BABY ASPIRIN), FINASTERIDE, ATORVASTATIN, TAMSULOSIN, METFORMIN HCL and MONTELUKAST for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm), CHILLS (chills), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headaches daily), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (nausea). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm), CHILLS (chills), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headaches daily), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Nausea, Pain in extremity, Productive cough
Clinical narrative: I've lost so much sleep,I can barely sleep; a lot of coughing every now and then; a lot of phlegm; soreness in my arm; chills; fever; tiredness; headaches daily; Muscle pain; Joint pain; nausea; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm) and CHILLS (chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure high. Concomitant products included INSULIN HUMAN (NOVOLIN R), INSULIN GLARGINE (LANTUS), ACETYLSALICYLIC ACID (BABY ASPIRIN), FINASTERIDE, ATORVASTATIN, TAMSULOSIN, METFORMIN HCL and MONTELUKAST for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm), CHILLS (chills), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headaches daily), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (nausea). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm), CHILLS (chills), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headaches daily), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I've lost so much sleep,I can barely sleep; a lot of coughing every now and then; a lot of phlegm; soreness in my arm; chills; fever; tiredness; headaches daily; Muscle pain; Joint pain; nausea; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm) and CHILLS (chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure high. Concomitant products included INSULIN HUMAN (NOVOLIN R), INSULIN GLARGINE (LANTUS), ACETYLSALICYLIC ACID (BABY ASPIRIN), FINASTERIDE, ATORVASTATIN, TAMSULOSIN, METFORMIN HCL and MONTELUKAST for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm), CHILLS (chills), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headaches daily), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (nausea). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INSOMNIA (I've lost so much sleep,I can barely sleep), COUGH (a lot of coughing every now and then), PRODUCTIVE COUGH (a lot of phlegm), PAIN IN EXTREMITY (soreness in my arm), CHILLS (chills), PYREXIA (fever), FATIGUE (tiredness), HEADACHE (headaches daily), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash, Vaccination site swelling
Clinical narrative: Pain around injection site; Swelling around injection site; rash around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain around injection site), VACCINATION SITE SWELLING (Swelling around injection site) and VACCINATION SITE RASH (rash around injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain around injection site), VACCINATION SITE SWELLING (Swelling around injection site) and VACCINATION SITE RASH (rash around injection site). On 11-Feb-2021, VACCINATION SITE PAIN (Pain around injection site), VACCINATION SITE SWELLING (Swelling around injection site) and VACCINATION SITE RASH (rash around injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product  was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-207669 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: TCR form received on 04-MAY-2021 and  does not contain any new information.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Headache, Injection site pain, Myalgia
Clinical narrative: scheduled for second dose 18 Feb 2021 but delayed due to snow storm; new appointment is now 12 Mar 2021, past the 36 day mark; headache; nausea; myalgia; chills; injection site pain; severe stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (severe stomach pain), PRODUCT AVAILABILITY ISSUE (scheduled for second dose 18 Feb 2021 but delayed due to snow storm), PRODUCT ADMINISTRATION INTERRUPTED (new appointment is now 12 Mar 2021, past the 36 day mark), HEADACHE (headache) and NAUSEA (nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history is provided. concomitant is provided.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (severe stomach pain), HEADACHE (headache), NAUSEA (nausea), MYALGIA (myalgia), CHILLS (chills) and INJECTION SITE PAIN (injection site pain). On an unknown date, the patient experienced PRODUCT AVAILABILITY ISSUE (scheduled for second dose 18 Feb 2021 but delayed due to snow storm) and PRODUCT ADMINISTRATION INTERRUPTED (new appointment is now 12 Mar 2021, past the 36 day mark). At the time of the report, ABDOMINAL PAIN UPPER (severe stomach pain), PRODUCT AVAILABILITY ISSUE (scheduled for second dose 18 Feb 2021 but delayed due to snow storm), PRODUCT ADMINISTRATION INTERRUPTED (new appointment is now 12 Mar 2021, past the 36 day mark), HEADACHE (headache), NAUSEA (nausea), MYALGIA (myalgia), CHILLS (chills) and INJECTION SITE PAIN (injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received no treatment for the events.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Product administration interrupted, Product availability issue
Clinical narrative: scheduled for second dose 18 Feb 2021 but delayed due to snow storm; new appointment is now 12 Mar 2021, past the 36 day mark; headache; nausea; myalgia; chills; injection site pain; severe stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (severe stomach pain), PRODUCT AVAILABILITY ISSUE (scheduled for second dose 18 Feb 2021 but delayed due to snow storm), PRODUCT ADMINISTRATION INTERRUPTED (new appointment is now 12 Mar 2021, past the 36 day mark), HEADACHE (headache) and NAUSEA (nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history is provided. concomitant is provided.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (severe stomach pain), HEADACHE (headache), NAUSEA (nausea), MYALGIA (myalgia), CHILLS (chills) and INJECTION SITE PAIN (injection site pain). On an unknown date, the patient experienced PRODUCT AVAILABILITY ISSUE (scheduled for second dose 18 Feb 2021 but delayed due to snow storm) and PRODUCT ADMINISTRATION INTERRUPTED (new appointment is now 12 Mar 2021, past the 36 day mark). At the time of the report, ABDOMINAL PAIN UPPER (severe stomach pain), PRODUCT AVAILABILITY ISSUE (scheduled for second dose 18 Feb 2021 but delayed due to snow storm), PRODUCT ADMINISTRATION INTERRUPTED (new appointment is now 12 Mar 2021, past the 36 day mark), HEADACHE (headache), NAUSEA (nausea), MYALGIA (myalgia), CHILLS (chills) and INJECTION SITE PAIN (injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received no treatment for the events.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Headache; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and ARTHRALGIA (joint pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 vaccination.     The patient's past medical history included Sickle cell disease.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (Headache) and ARTHRALGIA (joint pain). At the time of the report, HEADACHE (Headache) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided          No concomitant medications were reported. No Treatments were reported. Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Soreness; Pretty bad headache; Extremely Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), HEADACHE (Pretty bad headache) and FATIGUE (Extremely Tired) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN (Soreness) and HEADACHE (Pretty bad headache). 11-Mar-2021, the patient experienced FATIGUE (Extremely Tired). At the time of the report, PAIN (Soreness), HEADACHE (Pretty bad headache) and FATIGUE (Extremely Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  treatment medications provided by the reporter. No concomitant medications provided by the reporter.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity
Clinical narrative: on and off pain especially on quad muscle; pain in right leg; pain in right side of body,pain all over body,soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in right leg), PAIN (pain in right side of body,pain all over body,soreness) and MYALGIA (on and off pain especially on quad muscle) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in right leg) and PAIN (pain in right side of body,pain all over body,soreness). On 11-Mar-2021, the patient experienced MYALGIA (on and off pain especially on quad muscle). At the time of the report, PAIN IN EXTREMITY (pain in right leg), PAIN (pain in right side of body,pain all over body,soreness) and MYALGIA (on and off pain especially on quad muscle) outcome was unknown.            No concomitant medications were reported. Treatment included Pain medications. Action taken with mRNA-1273 in response to the events was not Applicable
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Renal colic
Clinical narrative: kidney stone problem really bad; low fever; running in temperature; This spontaneous case was reported by a consumer and describes the occurrence of RENAL COLIC (kidney stone problem really bad), PYREXIA (running in temperature) and PYREXIA (low fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included Kidney stone (she had 2 kidney stone 15 years ago reported.). Concurrent medical conditions included Drug allergy (Allergic to a lot of drugs, Vitamins Reported.).   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021 at 5:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (running in temperature). On 10-Mar-2021, the patient experienced RENAL COLIC (kidney stone problem really bad) and PYREXIA (low fever). At the time of the report, RENAL COLIC (kidney stone problem really bad), PYREXIA (running in temperature) and PYREXIA (low fever) outcome was unknown.            No Concomitant medications were reported. No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not Applicable
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site pain, Pyrexia
Clinical narrative: Fever of 99.8F; Chills; Sore at injection arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 99.8F), CHILLS (Chills) and INJECTION SITE PAIN (Sore at injection arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMOXYCILLIN [AMOXICILLIN] for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced INJECTION SITE PAIN (Sore at injection arm). On 20-Feb-2021, the patient experienced PYREXIA (Fever of 99.8F) and CHILLS (Chills). At the time of the report, PYREXIA (Fever of 99.8F), CHILLS (Chills) and INJECTION SITE PAIN (Sore at injection arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Pyrexia: inconclusive (Inconclusive) 99.8F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatments were reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Patient was pregnant while on the Moderna vaccine) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 immunisation. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 10-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient was pregnant while on the Moderna vaccine). On 10-Mar-2021, EXPOSURE DURING PREGNANCY (Patient was pregnant while on the Moderna vaccine) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication details was reported. No treatment medication details was reported.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus infection) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal, Parkinson's disease, Nerve pain and Cardiac disorder NOS.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinus infection). At the time of the report, SINUSITIS (sinus infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications sleep pill and medications for the indications for blood pressure, parkinson's disease, nerve pain, heart conditions.  No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Feeling abnormal, Headache
Clinical narrative: Head was killing me/ Headache; wasn't feeling that great on that night; It hurts all day since 2 weeks especially my eyes; This spontaneous case was reported by a health care professional and describes the occurrence of FEELING ABNORMAL (wasn't feeling that great on that night), EYE PAIN (It hurts all day since 2 weeks especially my eyes) and HEADACHE (Head was killing me/ Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. In February 2021, the patient experienced EYE PAIN (It hurts all day since 2 weeks especially my eyes). On 22-Feb-2021, the patient experienced FEELING ABNORMAL (wasn't feeling that great on that night). On 23-Feb-2021, the patient experienced HEADACHE (Head was killing me/ Headache). At the time of the report, FEELING ABNORMAL (wasn't feeling that great on that night) outcome was unknown, EYE PAIN (It hurts all day since 2 weeks especially my eyes) had not resolved and HEADACHE (Head was killing me/ Headache) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Nausea, Neck pain
Clinical narrative: Body ache; Feeling ache in neck as well as shoulder; Nausea; headache; fatigue; Fever; Feeling ache in neck as well as shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), NECK PAIN (Feeling ache in neck as well as shoulder), NAUSEA (Nausea), HEADACHE (headache) and FATIGUE (fatigue) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036AL1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (Body ache), NECK PAIN (Feeling ache in neck as well as shoulder), NAUSEA (Nausea), HEADACHE (headache), FATIGUE (fatigue), PYREXIA (Fever) and ARTHRALGIA (Feeling ache in neck as well as shoulder). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of UNK dosage form. In March 2021, NAUSEA (Nausea) and HEADACHE (headache) had resolved. At the time of the report, PAIN (Body ache), NECK PAIN (Feeling ache in neck as well as shoulder), FATIGUE (fatigue) and ARTHRALGIA (Feeling ache in neck as well as shoulder) had not resolved and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body ache; Feeling ache in neck as well as shoulder; Nausea; headache; fatigue; Fever; Feeling ache in neck as well as shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), NECK PAIN (Feeling ache in neck as well as shoulder), NAUSEA (Nausea), HEADACHE (headache) and FATIGUE (fatigue) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036AL1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (Body ache), NECK PAIN (Feeling ache in neck as well as shoulder), NAUSEA (Nausea), HEADACHE (headache), FATIGUE (fatigue), PYREXIA (Fever) and ARTHRALGIA (Feeling ache in neck as well as shoulder). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of UNK dosage form. In March 2021, NAUSEA (Nausea) and HEADACHE (headache) had resolved. At the time of the report, PAIN (Body ache), NECK PAIN (Feeling ache in neck as well as shoulder), FATIGUE (fatigue) and ARTHRALGIA (Feeling ache in neck as well as shoulder) had not resolved and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling, Pruritus, Rash erythematous
Clinical narrative: Itches; Still a little red; Arm was swollen; Itchy spot; Large red sore; Arm was red; Sore; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm was red), PAIN (Sore), RASH MACULAR (Large red sore), PRURITUS (Itches) and RASH ERYTHEMATOUS (Still a little red) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy and Drug allergy (Clindamycin).   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA (Arm was red) and PAIN (Sore). On 03-Mar-2021, the patient experienced RASH MACULAR (Large red sore) and VACCINATION SITE PRURITUS (Itchy spot). On an unknown date, the patient experienced PRURITUS (Itches), RASH ERYTHEMATOUS (Still a little red) and PERIPHERAL SWELLING (Arm was swollen). The patient was treated with HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Arm was red), PAIN (Sore), RASH MACULAR (Large red sore), PRURITUS (Itches), RASH ERYTHEMATOUS (Still a little red), PERIPHERAL SWELLING (Arm was swollen) and VACCINATION SITE PRURITUS (Itchy spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-131181 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: added dosage form, added event. added patient demographic, added historical condition; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-131181:2nd dose
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site pruritus
Clinical narrative: Itches; Still a little red; Arm was swollen; Itchy spot; Large red sore; Arm was red; Sore; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm was red), PAIN (Sore), RASH MACULAR (Large red sore), PRURITUS (Itches) and RASH ERYTHEMATOUS (Still a little red) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy and Drug allergy (Clindamycin).   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA (Arm was red) and PAIN (Sore). On 03-Mar-2021, the patient experienced RASH MACULAR (Large red sore) and VACCINATION SITE PRURITUS (Itchy spot). On an unknown date, the patient experienced PRURITUS (Itches), RASH ERYTHEMATOUS (Still a little red) and PERIPHERAL SWELLING (Arm was swollen). The patient was treated with HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Arm was red), PAIN (Sore), RASH MACULAR (Large red sore), PRURITUS (Itches), RASH ERYTHEMATOUS (Still a little red), PERIPHERAL SWELLING (Arm was swollen) and VACCINATION SITE PRURITUS (Itchy spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-131181 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: added dosage form, added event. added patient demographic, added historical condition; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-131181:2nd dose
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Swelling, Vaccination site induration, Vaccination site mass
Clinical narrative: experiencing inflammation under the ribcage; Hardness under the skin; a lump below the injection site, under the vaccination site there is a hard lump; as if the fluid had dropped and made a bump and it is the size of an olive; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (a lump below the injection site, under the vaccination site there is a hard lump), SWELLING (as if the fluid had dropped and made a bump and it is the size of an olive), INFLAMMATION (experiencing inflammation under the ribcage) and VACCINATION SITE INDURATION (Hardness under the skin) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX), LOSARTAN and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE MASS (a lump below the injection site, under the vaccination site there is a hard lump), SWELLING (as if the fluid had dropped and made a bump and it is the size of an olive) and VACCINATION SITE INDURATION (Hardness under the skin). On an unknown date, the patient experienced INFLAMMATION (experiencing inflammation under the ribcage). At the time of the report, VACCINATION SITE MASS (a lump below the injection site, under the vaccination site there is a hard lump), SWELLING (as if the fluid had dropped and made a bump and it is the size of an olive) and VACCINATION SITE INDURATION (Hardness under the skin) had resolved and INFLAMMATION (experiencing inflammation under the ribcage) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow up received on 24-Jun-2021 contains significant information including updated previous events outcome to recovered/resolved and added a new event.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea/she feels like she may vomit; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache) and NAUSEA (Nausea/she feels like she may vomit) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced HEADACHE (Severe headache). On 11-Mar-2021, the patient experienced NAUSEA (Nausea/she feels like she may vomit). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form, q4h. On 11-Mar-2021, HEADACHE (Severe headache) had resolved. At the time of the report, NAUSEA (Nausea/she feels like she may vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Soon after the vaccination her arm is Red and hot; Soon after the vaccination her arm is Red and hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Soon after the vaccination her arm is Red and hot) and VACCINATION SITE ERYTHEMA (Soon after the vaccination her arm is Red and hot) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (getting allergy shot every week).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Soon after the vaccination her arm is Red and hot) and VACCINATION SITE ERYTHEMA (Soon after the vaccination her arm is Red and hot). At the time of the report, VACCINATION SITE WARMTH (Soon after the vaccination her arm is Red and hot) and VACCINATION SITE ERYTHEMA (Soon after the vaccination her arm is Red and hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness around the injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer. Concomitant products included OSIMERTINIB MESILATE (TAGRISSO) for Cancer.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness around the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       The patient was given a topical ointment but it was still looking a little red and visited an acupuncturist.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pain
Clinical narrative: Lump the size of a baseball near injection site; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lump the size of a baseball near injection site) and VACCINATION SITE PAIN (Soreness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE MASS (Lump the size of a baseball near injection site) and VACCINATION SITE PAIN (Soreness). At the time of the report, VACCINATION SITE MASS (Lump the size of a baseball near injection site) and VACCINATION SITE PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Redness around injection site (left arm); It itches around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness around injection site (left arm)) and VACCINATION SITE PRURITUS (It itches around injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 036AZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Aspirin) and Drug allergy (Daypro).   On 25-Feb-2021 at 7:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021 at 7:25 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021 at 7:00 AM, the patient experienced VACCINATION SITE ERYTHEMA (Redness around injection site (left arm)) and VACCINATION SITE PRURITUS (It itches around injection site). On 06-Mar-2021, VACCINATION SITE ERYTHEMA (Redness around injection site (left arm)) had resolved. On 28-Mar-2021, VACCINATION SITE PRURITUS (It itches around injection site) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE ERYTHEMA (Redness around injection site (left arm)) and VACCINATION SITE PRURITUS (It itches around injection site) to be related.    Treatment details included Benadryl cream.   This case was linked to MOD-2021-105088 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Patient demographics, event start date and time, event stop date, event outcome, allergies and causality updated
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Lump in arm; Arm purple and blue; Lump turned itchy; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE MASS (Lump in arm), VACCINATION SITE BRUISING (Arm purple and blue) and VACCINATION SITE PRURITUS (Lump turned itchy) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE MASS (Lump in arm), VACCINATION SITE BRUISING (Arm purple and blue) and VACCINATION SITE PRURITUS (Lump turned itchy). At the time of the report, VACCINATION SITE MASS (Lump in arm), VACCINATION SITE BRUISING (Arm purple and blue) and VACCINATION SITE PRURITUS (Lump turned itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: headache; soreness in the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and VACCINATION SITE PAIN (soreness in the arm of the injection) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and VACCINATION SITE PAIN (soreness in the arm of the injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (headache) and VACCINATION SITE PAIN (soreness in the arm of the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Vertigo
Clinical narrative: Extreme vertigo; Dizziness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VERTIGO (Extreme vertigo) and DIZZINESS (Dizziness) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 11-Mar-2021, the patient experienced VERTIGO (Extreme vertigo) and DIZZINESS (Dizziness). At the time of the report, PAIN IN EXTREMITY (Sore arm), VERTIGO (Extreme vertigo) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Headache, Nausea, Pyrexia
Clinical narrative: Headache, nausea, extreme pain across her shoulder blade, and fever; Headache, nausea, extreme pain across her shoulder blade, and fever; Symptoms seem to occur in cycles where she feels good for a bit and then she "crashes."; Headache, nausea, extreme pain across her shoulder blade, and fever; Headache, nausea, extreme pain across her shoulder blade, and fever; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Symptoms seem to occur in cycles where she feels good for a bit and then she "crashes."), HEADACHE (Headache, nausea, extreme pain across her shoulder blade, and fever), NAUSEA (Headache, nausea, extreme pain across her shoulder blade, and fever), ARTHRALGIA (Headache, nausea, extreme pain across her shoulder blade, and fever) and PYREXIA (Headache, nausea, extreme pain across her shoulder blade, and fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CONDITION AGGRAVATED (Symptoms seem to occur in cycles where she feels good for a bit and then she "crashes."), HEADACHE (Headache, nausea, extreme pain across her shoulder blade, and fever), NAUSEA (Headache, nausea, extreme pain across her shoulder blade, and fever) and PYREXIA (Headache, nausea, extreme pain across her shoulder blade, and fever). On 11-Mar-2021, the patient experienced ARTHRALGIA (Headache, nausea, extreme pain across her shoulder blade, and fever). At the time of the report, CONDITION AGGRAVATED (Symptoms seem to occur in cycles where she feels good for a bit and then she "crashes."), HEADACHE (Headache, nausea, extreme pain across her shoulder blade, and fever), NAUSEA (Headache, nausea, extreme pain across her shoulder blade, and fever), ARTHRALGIA (Headache, nausea, extreme pain across her shoulder blade, and fever) and PYREXIA (Headache, nausea, extreme pain across her shoulder blade, and fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness, Feeling hot, Nausea
Clinical narrative: Weakness; Diarrhea; Red knot two inches around arm; Red knot two inches around arm; Arm swelling; got up and felt heat up legs into entire body; lightheaded,thought I was going to faint; Vommiting; arm itching; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIARRHOEA (Diarrhea), FEELING HOT (got up and felt heat up legs into entire body), DIZZINESS (lightheaded,thought I was going to faint) and VACCINATION SITE PRURITUS (arm itching) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Broken bones (22 broken bones due to car accident) and Brain injury (due to car accident). Concurrent medical conditions included Non-Hodgkin's lymphoma. Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), DULOXETINE HYDROCHLORIDE (CYMBALTA), PANTOPRAZOLE, BUPROPION HYDROCHLORIDE (WELLBUTRIN), LAMOTRIGINE (LAMICTAL), ALPRAZOLAM (XANAX), LACTOBACILLUS ACIDOPHILUS (ACIDOPHILUS [LACTOBACILLUS ACIDOPHILUS]), BIOTIN and COLECALCIFEROL (D3) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (arm itching) and NAUSEA (nausea). On 19-Feb-2021, the patient experienced VOMITING (Vommiting). On 28-Feb-2021, the patient experienced FEELING HOT (got up and felt heat up legs into entire body) and DIZZINESS (lightheaded,thought I was going to faint). On an unknown date, the patient experienced ASTHENIA (Weakness), DIARRHOEA (Diarrhea), VACCINATION SITE INDURATION (Red knot two inches around arm), VACCINATION SITE ERYTHEMA (Red knot two inches around arm) and VACCINATION SITE SWELLING (Arm swelling). At the time of the report, ASTHENIA (Weakness), DIARRHOEA (Diarrhea), FEELING HOT (got up and felt heat up legs into entire body), DIZZINESS (lightheaded,thought I was going to faint), VACCINATION SITE PRURITUS (arm itching), VACCINATION SITE INDURATION (Red knot two inches around arm), VACCINATION SITE SWELLING (Arm swelling) and VOMITING (Vommiting) outcome was unknown and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.